Zampilimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zampilimab, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]